CME Information

ACCME Accreditation

The American College of Obstetricians and Gynecologists is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

AMA PRA Category 1 Credit(s)™

The American College of Obstetricians and Gynecologists designates this live activity for a maximum of 9.25 AMA PRA Category 1 Credits.™  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

College Cognate Credit(s)

The American College of Obstetricians and Gynecologists designates this live activity for a maximum of 9.25 Category 1 College Cognate Credits. The College has a reciprocity agreement with the AMA that allows AMA PRA Category 1 Credits™ to be equivalent to College Cognate Credits.

LEARNING OBJECTIVES

At the end of this activity, participants will be able to:

  1. Apply updated medical information and knowledge to improve care in obstetrics and gynecology.

  2. Learn strategies at the individual and systematic level to improve reimbursement for ob-gyn physicians.
  3. Incorporate new tools, systems and an expanded knowledge to improve clinical efficiency in the diagnosis and treatment of obstetric and gynecologic disorders.

TARGET AUDIENCE

This educational activity is designed for clinicians caring for obstetric and gynecologic patients, including ob-gyns, residents, medical students, nurses, midwives and other clinicians.

DISCLOSURE POLICY

The faculty, committee members, and staff who are in position to control the content of this activity are required to disclose to ACOG and to learners any financial relationship(s) of the individual that have occurred within the last 24 months with any ineligible entities whose products are related to the continuing education content. Financial relationships are defined by remuneration in any amount from the ineligible entities in the form of grants; research support; consulting fees; salary; ownership interest (e.g., stocks, stock options, or ownership interest excluding diversified mutual funds); honoraria or other payments for participation in speakers’ bureaus, advisory boards, or boards of directors; or other financial benefits. The intent of this disclosure is not to prevent planners with relevant financial relationships from planning or delivering content, but rather to provide learners with information that allows them to make their own judgments of whether these financial relationships may have influenced the educational activity with regard to exposition or conclusion. ACOG and has reviewed all disclosures and resolved or managed all identified conflicts of interest, as applicable.

ALL RELEVANT FINANCIAL RELATIONSHIPS HAVE BEEN MITIGATED

The following activity planning members reported financial relationship(s):

  • Rachel Villanueva, MD – Medical Advisor: ExpectFit, and FemGevity; Speaker: Astellas; Speaker/RSV US Commercial Advisory Board and BREATHE Steering Committee

The following activity planning members reported no financial relationships:

  • Heather Link, MD
  • Christine Herde, MD
  • Tejasvi Gowda, MD
  • Laura Kim, MD
  • Naj Gabbur, MD
  • Kiera Parrish, MD
  • Christa Christakis

The following activity faculty members reported financial relationship(s):

  • Samantha Deans, MD - Nexplanon Clinical Trainer: Organon
  • Rachel Flink-Bonchacki, MD - Nexplanon Trainer: Organon
  • Mia Keeys - Director of Federal Affairs: Hologic, Inc.
  • Mary Minkin, MD - Consultant: Astellas, Mayne Pharmaceuticals, Pfizer, Bonafide, Bayer, Schaper Und Brummer, and TherapeuticsMD

ALL OTHER FACULTY/PLANNING COMMITTEE MEMBERS/REVIEWERS/STAFF HAVE NO RELEVANT FINANCIAL RELATIONSHIPS WITH INELIGIBLE COMPANIES.

CONTENT VALIDITY

All recommendations involving clinical medicine are based on evidence accepted within the profession of medicine as adequate justification for their indications and contraindications in the care of patients; AND/OR All scientific research referred to or reported in support or justification of a patient care recommendation conforms to generally accepted standards of experimental design, data collection, and analysis.

ACKNOWLEDGMENT OF COMMERCIAL SUPPORT

This activity is supported in part by an educational grant from Hologic.

ELIGIBILITY TO EARN CONTINUING EDUCATION CREDIT

CME certificates are provided to registered participants based on the successful completion of the activity, in its entirety, including the activity evaluation.

RELEASE DATE: September 27, 2024
EXPIRATION DATE: September 28, 2024